Literature DB >> 24811598

Flushing the central venous catheter: is heparin necessary?

Alberto Dal Molin1, Elias Allara, Doriana Montani, Simona Milani, Cristina Frassati, Simonetta Cossu, Simone Tonella, Dania Brioschi, Laura Rasero.   

Abstract

PURPOSE: The aim of this systematic review was to assess the efficacy of heparin flushing in the lock of central venous catheters.
METHODS: We searched MEDLINE and CINAHL databases. Eligible studies were randomized controlled trials evaluating the use of heparin versus normal saline or other solution in the flushing of central catheter among adult patients. No language restrictions were applied. Two reviewers independently screened titles and abstracts in order to identify relevant publications. The same two reviewers retrieved and evaluated full texts. Parameter estimates regarding catheter occlusion were pooled using network meta-analysis with Bayesian hierarchical modeling.
RESULTS: We identified 462 references. Eight studies were included. There was no evidence that heparin was more effective than normal saline in reducing occlusions. It was unclear whether urokinase and lepirudin were more effective than heparin in reducing occlusions. Vitamin C solution does not appear to prolong catheter patency.
CONCLUSIONS: There is no evidence of a different effectiveness between heparin flushing and normal saline or other solutions in reducing catheter occlusions. Due to the little and inconclusive evidence available in this field, further studies might be necessary.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24811598     DOI: 10.5301/jva.5000225

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  8 in total

Review 1.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 2.  Flushing and Locking of Venous Catheters: Available Evidence and Evidence Deficit.

Authors:  Godelieve Alice Goossens
Journal:  Nurs Res Pract       Date:  2015-05-14

Review 3.  Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.

Authors:  Lei Zhong; Hai-Li Wang; Bo Xu; Yao Yuan; Xin Wang; Ying-Ying Zhang; Li Ji; Zi-Mu Pan; Zhan-Sheng Hu
Journal:  Crit Care       Date:  2017-01-08       Impact factor: 9.097

4.  Comparison of heparinized saline and 0.9% sodium chloride for maintaining central venous catheter patency in healthy dogs.

Authors:  Julieann Vose; Adesola Odunayo; Joshua M Price; Maggie Daves; Julie C Schildt; M Katherine Tolbert
Journal:  PeerJ       Date:  2019-05-31       Impact factor: 2.984

Review 5.  Heparin flush vs. normal saline flush to maintain the patency of central venous catheter among adult patients: A systematic review and meta-analysis.

Authors:  Suresh K Sharma; Shiv K Mudgal; Rakhi Gaur; Rakesh Sharma; Maneesh Sharma; Kalpana Thakur
Journal:  J Family Med Prim Care       Date:  2019-09-30

6.  Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.

Authors:  Marlena Ornowska; Hubert Wong; Yongdong Ouyang; Anish Mitra; Aaron White; Sue Willems; Jessica Wittmann; Steven Reynolds
Journal:  Trials       Date:  2022-08-30       Impact factor: 2.728

Review 7.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30

8.  The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience.

Authors:  Mairead McLoughlin; Karolina M Stepien; Briony McNelly; Lorraine Thompson; Janet Gorton; Christian J Hendriksz
Journal:  Mol Genet Metab Rep       Date:  2017-10-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.